JP2014210824A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014210824A5 JP2014210824A5 JP2014168689A JP2014168689A JP2014210824A5 JP 2014210824 A5 JP2014210824 A5 JP 2014210824A5 JP 2014168689 A JP2014168689 A JP 2014168689A JP 2014168689 A JP2014168689 A JP 2014168689A JP 2014210824 A5 JP2014210824 A5 JP 2014210824A5
- Authority
- JP
- Japan
- Prior art keywords
- gastritis
- treatment
- prostaglandin
- prevention
- agonist component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 208000007882 Gastritis Diseases 0.000 claims 4
- 241000124008 Mammalia Species 0.000 claims 3
- 239000000556 agonist Substances 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 150000003180 prostaglandins Chemical class 0.000 claims 3
- 238000011282 treatment Methods 0.000 claims 3
- 208000004300 Atrophic Gastritis Diseases 0.000 claims 2
- 208000036495 Gastritis atrophic Diseases 0.000 claims 2
- 241000590002 Helicobacter pylori Species 0.000 claims 2
- 208000031845 Pernicious anaemia Diseases 0.000 claims 2
- 208000016644 chronic atrophic gastritis Diseases 0.000 claims 2
- 201000001564 eosinophilic gastroenteritis Diseases 0.000 claims 2
- 229940037467 helicobacter pylori Drugs 0.000 claims 2
- 230000002980 postoperative effect Effects 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 230000006806 disease prevention Effects 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87044406P | 2006-12-18 | 2006-12-18 | |
| US60/870,444 | 2006-12-18 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009543060A Division JP2010513551A (ja) | 2006-12-18 | 2007-12-11 | 胃腸疾患の治療方法および組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014210824A JP2014210824A (ja) | 2014-11-13 |
| JP2014210824A5 true JP2014210824A5 (https=) | 2014-12-25 |
Family
ID=39059771
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009543060A Ceased JP2010513551A (ja) | 2006-12-18 | 2007-12-11 | 胃腸疾患の治療方法および組成物 |
| JP2014168689A Ceased JP2014210824A (ja) | 2006-12-18 | 2014-08-21 | 胃腸疾患の治療方法および組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009543060A Ceased JP2010513551A (ja) | 2006-12-18 | 2007-12-11 | 胃腸疾患の治療方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20100081631A1 (https=) |
| EP (3) | EP2120962A1 (https=) |
| JP (2) | JP2010513551A (https=) |
| AU (1) | AU2007334038A1 (https=) |
| BR (1) | BRPI0721067A2 (https=) |
| CA (1) | CA2690273A1 (https=) |
| WO (1) | WO2008076703A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7855226B2 (en) | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| US8580954B2 (en) | 2006-03-28 | 2013-11-12 | Hospira, Inc. | Formulations of low dose diclofenac and beta-cyclodextrin |
| US20090012165A1 (en) * | 2007-07-03 | 2009-01-08 | Sucampo Ag | Pharmaceutical combination of nsaid and prostaglandin compound |
| KR20130130694A (ko) * | 2010-07-30 | 2013-12-02 | 알러간, 인코포레이티드 | 피부 재생을 위한 화합물과 방법 |
| US20120142684A1 (en) * | 2010-12-02 | 2012-06-07 | Allergan, Inc. | Compounds and methods for skin repair |
| RU2586040C1 (ru) * | 2014-12-25 | 2016-06-10 | Государственное бюджетное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия" Министерства Здравоохранения Российской Федерации (ГБОУ ВПО НижГМА Минздрава России) | Способ диагностики идиопатической язвенной болезни желудка и двенадцатиперстной кишки |
| CN107849072B (zh) | 2015-06-12 | 2020-12-15 | 西蒙弗雷泽大学 | 酰胺连接的ep4激动剂-二膦酸盐化合物及其用途 |
| NL2018407B1 (en) * | 2017-02-22 | 2018-09-17 | Skytree B V | Improved process and apparatus for the removal of metabolic carbon dioxide from a confined space |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL110298A (en) | 1993-07-13 | 1999-04-11 | Brann Mark Robert | Identification of ligands by selective amplification of cells transfected with receptors |
| KR20010074981A (ko) | 1998-09-14 | 2001-08-09 | 우에노 도시오 | ω치환된 페닐프로스타그란딘 Ｅ 유도체 및 그 유도체를유효 성분으로 하는 약제 |
| OA12533A (en) * | 2000-11-27 | 2006-06-05 | Pfizer Prod Inc | Ep4 receptor selective agonists in the treatment of osteoporosis. |
| AU2003211574A1 (en) * | 2002-03-05 | 2003-09-16 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| US7855226B2 (en) | 2003-02-11 | 2010-12-21 | Allergan, Inc. | Treatment of inflammatory bowel disease |
| AU2005299473B2 (en) * | 2004-10-26 | 2012-06-28 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin EP4 agonists |
| US7893107B2 (en) * | 2005-11-30 | 2011-02-22 | Allergan, Inc. | Therapeutic methods using prostaglandin EP4 agonist components |
| US20070232660A1 (en) * | 2006-04-04 | 2007-10-04 | Allergan, Inc. | Therapeutic and delivery methods of prostaglandin ep4 agonists |
-
2007
- 2007-12-11 EP EP07855057A patent/EP2120962A1/en not_active Ceased
- 2007-12-11 BR BRPI0721067-1A patent/BRPI0721067A2/pt not_active IP Right Cessation
- 2007-12-11 CA CA2690273A patent/CA2690273A1/en not_active Abandoned
- 2007-12-11 US US12/519,215 patent/US20100081631A1/en not_active Abandoned
- 2007-12-11 AU AU2007334038A patent/AU2007334038A1/en not_active Abandoned
- 2007-12-11 EP EP12188643A patent/EP2548559A1/en not_active Withdrawn
- 2007-12-11 WO PCT/US2007/087042 patent/WO2008076703A1/en not_active Ceased
- 2007-12-11 EP EP12159850A patent/EP2465506A1/en not_active Withdrawn
- 2007-12-11 JP JP2009543060A patent/JP2010513551A/ja not_active Ceased
-
2014
- 2014-08-21 JP JP2014168689A patent/JP2014210824A/ja not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014210824A5 (https=) | ||
| NZ624922A (en) | Orally administered corticosteroid compositions | |
| HK1218560A1 (zh) | 组成与方法 | |
| WO2011099832A3 (en) | Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same | |
| JP2013014622A5 (https=) | ||
| RU2019131148A (ru) | Лечение злокачественных опухолей с использованием модуляторов изоформ pi3-киназы | |
| JP2019516735A5 (https=) | ||
| JP2013525444A5 (https=) | ||
| DOP2017000294A (es) | Unidad de dosificación orodispersable que contiene un componente estetrol | |
| JP2013032389A5 (https=) | ||
| JP2015110588A5 (https=) | ||
| EA201001781A1 (ru) | Применение гликозаминогликанов для перорального введения и композиции гликозаминогликанов | |
| JP2011527299A5 (https=) | ||
| MX2018003975A (es) | Combinacion de glicosaminoglicanos y un agente antacido y sus composiciones. | |
| JP2014218522A5 (https=) | ||
| SA517390550B1 (ar) | وحدة جرعة قابلة للتفتت في الفم تتضمن مكون أستيترول | |
| EP2956149A4 (en) | PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI | |
| WO2016168553A8 (en) | Deuterated obeticholic acid | |
| JP2012528856A5 (https=) | ||
| WO2016040814A3 (en) | Disulfide polymers and methods of use | |
| JP2016515123A5 (https=) | ||
| EA201691034A1 (ru) | Композиции в твердой форме с замедленным высвобождением для перорального введения | |
| JP2009505991A5 (https=) | ||
| JP2018504391A5 (https=) | ||
| JP2016535762A5 (https=) |